Literature DB >> 9292733

A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion.

Y Li1, P Maher, D Schubert.   

Abstract

An early and highly specific decrease in glutathione (GSH) in the substantia nigra is associated with Parkinson's disease, and low levels of GSH lead to the degeneration of cultured dopaminergic neurons. Using immature cortical neurons and a clonal nerve cell line, it is shown that a decrease in GSH triggers the activation of neuronal 12-lipoxygenase (12-LOX), which leads to the production of peroxides, the influx of Ca2+, and ultimately to cell death. The supporting evidence includes: 1) inhibitors of arachidonate metabolism and 12-LOX block cell death induced by GSH depletion; 2) there is an increase in 12-LOX activity and a membrane translocation in HT22 cells, and an induction of the enzyme in primary cortical neurons following the reduction of GSH; 3) 12-LOX is directly inhibited by GSH; and 4) exogenous arachidonic acid potentiates cell death. These data show that the LOX pathway is a critical intermediate in at least some forms of neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292733     DOI: 10.1016/s0896-6273(00)80953-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  162 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Authors:  J D Sinor; S Du; S Venneti; R C Blitzblau; D N Leszkiewicz; P A Rosenberg; E Aizenman
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  Oxidative glutamate toxicity can be a component of the excitotoxicity cascade.

Authors:  D Schubert; D Piasecki
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 4.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

5.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

Review 6.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 7.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

8.  Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes.

Authors:  Jianrong Li; Hong Wang; Paul A Rosenberg
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

9.  Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.

Authors:  Hoon Ryu; Junghee Lee; Beatrix A Olofsson; Aziza Mwidau; Alpaslan Dedeoglu; Maria Escudero; Erik Flemington; Jane Azizkhan-Clifford; Robert J Ferrante; Rajiv R Ratan; Alpaslan Deodoglu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-14       Impact factor: 11.205

10.  The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress.

Authors:  Y Sagara; D Schubert
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.